跳至主要内容
临床试验/NCT01325493
NCT01325493已完成4 期

Modulation of μ Opioid Receptor Mediated Analgesia, Tolerance and Hyperalgesia in Children and Adolescents

Julia Finkel1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Morphine Equivalent Consumption (mg/kg)

研究概览

简要总结

The purpose of this study is to:

  1. Establish whether ketamine can decrease opioid consumption and modulate the onset of opioid tolerance and prevent opioid-induced hyperalgesia in pediatric subjects, ages 10 years to 18 years, undergoing posterior spinal fusion and instrumentation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • The subject is 10 to 18 years of age
  • The subject's American Society of Anesthesiologists physical status is ASA 1, 2 or 3 (see appendix I)
  • The subject is scheduled for elective posterior spinal fusion and instrumentation.
  • The subject's parent/legally authorized guardian has given written informed consent to participate

排除标准

  • The subject has a history or a family (parent or sibling) history of malignant hyperthermia
  • The subject is pregnant or nursing.
  • The subject has known significant renal disorders determined by medical history, physical examination or laboratory tests
  • The subject has a known or suspected allergy to morphine, remifentanil or ketamine
  • The subject is an ASA classification of 4 or greater (See Appendix I)
  • The subject is scheduled for a surgical sub-procedure (i.e. anterior spinal fusion)
  • The subject is unable to self-administer morphine using patient-controlled analgesia (PCA) pump
  • The subject had a recent opioid exposure (within 1 month of surgery)
  • The subject is obese (body mass index >30kg/m2)
  • The subject is planned for elective postoperative ventilation
  • The subject has a known ocular disease not permitting pupillometric examination
  • The subject has used any investigation products in the past 30 days

研究组 & 干预措施

Normal Saline

Placebo Comparator

Normal Saline given 0.5mg/kg intravenous (IV) load followed by an intraoperative continuous infusion at 0.25mg/kg/h and a postoperative infusion at 0.1mg/kg/h

干预措施: Normal Saline (Drug)

Ketamine

Active Comparator

ketamine 0.5mg/kg intravenous (IV) load followed by an intraoperative continuous infusion at 0.25mg/kg/h and a postoperative infusion at 0.1mg/kg/h

干预措施: Ketamine (Drug)

结局指标

主要结局

Morphine Equivalent Consumption (mg/kg)

时间窗: at 24, 48, 72, 96 hours post operatively

Morphine consumption (mg/kg) was measured over time in the Ketamine group and compared to the Control (saline) group. Values are for each 24 hour time period and displayed as hours post surgery.

次要结局

  • Sedation Score(24, 48, 72, 96 hours post operatively)
  • Pain Score During Cough.(24, 48, 72, 96 hours post operatively)
  • Pain Score at Rest(24, 48, 72, 96 hours post operatively)

研究者

发起方
Julia Finkel
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Julia Finkel

Director of Research

Children's National Research Institute

研究点 (1)

Loading locations...

相似试验

Low Dose Ketamine Study on Opioid Tolerance and... | 临床试验